International Clinical Trial: Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet Therapy (Aspirin and Clopidogrel)

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853612) titled 'Effect of Two Weeks of Low-Dose Apixaban on Platelet Reactivity in Patients With Stable Coronary Artery Disease on Dual Antiplatelet Therapy (Aspirin and Clopidogrel)' on Sept. 26.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: The University of The West Indies

Condition: Coronary Artery Disease High On-treatment Platelet Reactivity (HTPR)

Intervention: Drug: Apixaban

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 3, 2026

Target Sample ...